Peptomyc — Seed · €1M

Peptomyc completed a €1M seed round led by Healthequity SCR, joined by a group of business angels and institutional investors. The funds were for completing preclinical validation of its Omomyc-based lead candidate in glioblastoma and in other cancers.

LeadHealthequity, Riva y García RoundSeed Announced28 Apr 2016 CityBarcelona SectorHealthtech & Bio · Biotech Source H

Something wrong? Suggest a correction →